News

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The FDA recommended different standards of evidence for approval based on patients' risk of getting severely sick from Covid.
Top officials for the Food and Drug Administration laid out new requirements for yearly updates to COVID shots, saying they’d ...
Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...
The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...
"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...
The Trump administration announced Tuesday that going forward, COVID-19 vaccines would be FDA-approved only for people over ...